Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease

被引：310

作者：

Yates, Clara M. ^{[1
]}

Calder, Philip C. ^{[2
]}

Rainger, G. Ed ^{[1
]}

机构：

[1] Univ Birmingham, Sch Clin & Expt Med, Ctr Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England

[2] Univ Southampton, Fac Med, Human Dev & Hlth Acad Unit, Southampton SO16 6YD, Hants, England

来源：

PHARMACOLOGY & THERAPEUTICS | 2014年 / 141卷 / 03期

关键词：

Omega-3 polyunsaturated fatty acid; Eicosapentaenoic acid; Docosahexaenoic acid; Inflammation; Eicosanoid; Resolvin; FISH-OIL SUPPLEMENTATION; TUMOR-NECROSIS-FACTOR; RANDOMIZED CONTROLLED-TRIAL; PROLIFERATOR-ACTIVATED RECEPTORS; CYTOKINE-INDUCED EXPRESSION; EUROPEAN PROSPECTIVE COHORT; PLACEBO-CONTROLLED TRIAL; ALPHA-LINOLENIC ACID; NF-KAPPA-B; DOCOSAHEXAENOIC ACID;

D O I：

10.1016/j.pharmthera.2013.10.010

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Omega-3 (n-3) polyunsaturated fatty acids (n-3 PUFAs) have well documented anti-inflammatory properties, and consequently therapeutic potential in chronic inflammatory diseases. Here we discuss the effects of n-3 PUFAs on various inflammatory pathways and how this leads to alterations in the function of inflammatory cells, most importantly endothelial cells and leukocytes. Strong evidence indicates n-3 PUFAs are beneficial as a dietary supplement in certain diseases such as rheumatoid arthritis; however for other conditions such as asthma, the data are less robust. A clearer understanding of the pharmacology of n-3 PUFAs will help to establish targets to modulate chronic inflammatory diseases. (C) 2013 Elsevier Inc. All rights reserved.

引用

页码：272 / 282

页数：11

共 50 条

[1] Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? [J].

Calder, Philip C. .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (03) :645-662

[2] Omega-3 Polyunsaturated Fatty Acids in the Treatment of Kidney Disease [J].

Fassett, Robert G. ;

Gobe, Glenda C. ;

Peake, Jonathan M. ;

Coombes, Jeff S. .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 56 (04) :728-742

[3] Understanding Omega-3 Polyunsaturated Fatty Acids [J].

Calder, Philip C. ;

Yaqoob, Parveen .

POSTGRADUATE MEDICINE, 2009, 121 (06) :148-157

[4] Omega-3 polyunsaturated fatty acids [J].

Hull, Mark A. .

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2011, 25 (4-5) :547-554

[5] Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits [J].

Shahidi, Fereidoon ;

Ambigaipalan, Priyatharini .

ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 9, 2018, 9 :345-381

[6] Omega-3 Polyunsaturated Fatty Acids and Cancer [J].

Jing, Kaipeng ;

Wu, Tong ;

Lim, Kyu .

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2013, 13 (08) :1162-1177

[7] Omega-3 polyunsaturated fatty acids and oxygenated metabolism in atherothrombosis [J].

Guichardant, Michel ;

Calzada, Catherine ;

Bernoud-Hubac, Nathalie ;

Lagarde, Michel ;

Vericel, Evelyne .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2015, 1851 (04) :485-495

[8] Omega-3 Polyunsaturated Fatty Acids and Depression: A Review of the Evidence [J].

Liperoti, R. ;

Landi, F. ;

Fusco, O. ;

Bernabei, R. ;

Onder, G. .

CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (36) :4165-4172

[9] Omega-3 Polyunsaturated Fatty Acids in Physical Performance Optimization [J].

Mickleborough, Timothy D. .

INTERNATIONAL JOURNAL OF SPORT NUTRITION AND EXERCISE METABOLISM, 2013, 23 (01) :83-96

[10] Cardioprotective mechanism of omega-3 polyunsaturated fatty acids [J].

Endo, Jin ;

Arita, Makoto .

JOURNAL OF CARDIOLOGY, 2016, 67 (1-2) :22-27

← 1 2 3 4 5 →